Ressources

Bienvenue dans notre banque interrogeable de ressources et de documentation sur l’approvisionnement plus sécuritaire et autres sujets connexes.

 

 

No studies to date have described PWUD's perspectives from a real-world setting about ideal fentanyl test strip (FTS) program characteristics.

Original research | 2022
Drug checking, Illegal drugs, About PWUD, Harm reduction

The aim of this study is to explore caregivers’ experiences accessing opioid use treatments with young people and their needs and ideas for improving such treatments.

Original research | 2022
Youth, Illegal drugs, Parents/caregivers, Policy/Regulatory

It is critical to develop empirically based, community-treatment friendly, psychotherapy interventions to improve treatment for patients with comorbid chronic pain and Opioid Use Disorder.

Original research | 2022
About PWUD, Chronic pain

We describe self-reported challenges obtaining prescription opioids among people prescribed opioids long-term for chronic non-cancer pain (CNCP) and explore associations with participant and treatm

Original research | 2022
Chronic pain, About PWUD

We assessed the effects of COVID-19-related changes on take-home methadone dosing in two opioid treatment programs serving five rural Oregon counties.

Original research | 2022
Policy/Regulatory, About PWUD, Outcomes, Illegal drugs, Substitution/OAT, Carries/take-home doses

The goal of this study was to identify provider factors that could drive differences in treatment retention while accounting for the contribution of patient characteristics to retention.

Original research | 2022
Equity, About prescribers, Barriers and enablers, Outcomes
Commentary | 2022
Harm reduction, Policy/Regulatory, Barriers and enablers, About PWUD, Illegal drugs, Youth, SCS/OPS

This study examined disparities in years of potential life lost (YPLL) related to opioid use among racial and ethnic groups adjusting for individual- and neighborhood-level characteristics.

Original research | 2022
Overdose, Mortality, About PWUD, Equity

This study evaluated factors associated with 60-day adherence to novel opioid alternatives prescribed at an inner-city health centre in Victoria, Canada.

Original research | 2022
Mental health, About PWUD, Safer supply, Evidence base, Outcomes

Our study aimed to uncover the role police perceive for themselves at overdose events.

Original research | 2022
Legal system/law enforcement, Overdose, Policy/Regulatory

This study examined:

Infographic | 2022
Barriers and enablers, About PWUD, Hospitals, Hesitancy of prescribers , Equity, Chronic pain, Stigma

We sought to determine the prevalence of health care avoidance and its association with emergency department use among PWUD and examine patient-reported nonmedical qualities of health care (“respon

Original research | 2022
Barriers and enablers, About PWUD, Hospitals, Hesitancy of prescribers , Equity, Chronic pain, Stigma

In this exploratory analysis, we investigated whether changes in the unregulated opioid drug supply are associated with income assistance payment weeks.

Original research | 2022
Overdose, Drug checking, Illegal drugs

This study evaluated disparities in naloxone prescribing for patients who presented after opioid overdose in a large health system.

Original research | 2022
Overdose, Harm reduction, About prescribers, Hospitals

Establish standards of conduct for our interactions and relationships at work, as they relate to substance use and its intersections.

Policy | 2022
Policy/Regulatory, Workplace, Illegal drugs
Manuel | 2022
à propos des prescripteurs, le traitement de substitution/TAO
Guide or handbook | 2022
About prescribers, Substitution/OAT

The COVID-19 pandemic and associated mitigation strategies may have increased overdose risk for people who use drugs by impacting social, community, and structural factors.

Original research | 2022
About PWUD, Overdose, Stigma, Mental health, Rural/remote
Commentary | 2020
Stimulants, About prescribers, Illegal drugs

Affiner votre recherche

Mots clés
Format
Région